Pharm stocks so a significant spike after news of Operation Warp Speed to fund NVAX for phase 3 clinical trials.  Small Cap stocks such as VBIV, HEPA, CRVS, VXRT so significant gains mid day but consolidated toward market close except VXRT.  ANVS saw a gap up on news of IRB approval for lead drug in Alzheimers and Parkinsons patients along with strong equities offerings. 

EV sector took a back seat to BioTech stock but best plays were a short on WKHS or a long on NIO. NIO is showing similar stair step pattern of WKHS just 10 days later.   

 

---

VBIV- Watching after hours if it can hold at market open.  May be a great morning day bounce buy.  

Great Trade-3

---

HEPA- Looking for breakout on great news of preclinical trial. 

 https://seekingalpha.com/news/3589030-hepion-pharmas-lead-candidate-shows-encouraging-action-in-covidminus-19-models

Good Trade-2

---

CRVS- Looking for breakout from 5.45 resistance.  News of Phase 1 Study 

https://seekingalpha.com/news/3589010-corvus-pharma-on-go-to-launch-immunotherapy-study-for-covidminus-19

Good Trade-2